Fluidigm Inks Scandinavia Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm today said that it has signed an agreement with AH Diagnostics to serve as its exclusive distributor in Sweden, Norway, Denmark, Iceland, and Finland.

Starting Feb. 1, Aarhus, Denmark-based AH will offer Fluidigm's portfolio of BioMark HD, EP1, and Access Array Systems and its arrays for a variety of genomic applications, including the new Deltagene and SNPtype arrays. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.